5rl3: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "5rl3" [edit=sysop:move=sysop] |
No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhibitors -- Crystal Structure of SARS-CoV-2 main protease in complex with LON-WEI-adc59df6-39 (Mpro-x3117)== | |||
<StructureSection load='5rl3' size='340' side='right'caption='[[5rl3]], [[Resolution|resolution]] 1.51Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5RL3 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5RL3 FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.51Å</td></tr> | |||
[[Category: | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=VEP:N-(4-tert-butylphenyl)-N-[(1R)-2-[(oxan-4-yl)amino]-2-oxo-1-(pyridin-3-yl)ethyl]propanamide'>VEP</scene></td></tr> | ||
[[Category: Aimon | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5rl3 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5rl3 OCA], [https://pdbe.org/5rl3 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5rl3 RCSB], [https://www.ebi.ac.uk/pdbsum/5rl3 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5rl3 ProSAT]</span></td></tr> | ||
[[Category: | </table> | ||
[[Category: | __TOC__ | ||
[[Category: | </StructureSection> | ||
[[Category: Dunnett | [[Category: Large Structures]] | ||
[[Category: | [[Category: Aimon A]] | ||
[[Category: | [[Category: Brandao-Neto J]] | ||
[[Category: | [[Category: Carbery A]] | ||
[[Category: | [[Category: Douangamath A]] | ||
[[Category: | [[Category: Dunnett L]] | ||
[[Category: | [[Category: Fearon D]] | ||
[[Category: | [[Category: Gehrtz P]] | ||
[[Category: Powell | [[Category: Gorie-Stone TJ]] | ||
[[Category: Skyner | [[Category: Krojer T]] | ||
[[Category: | [[Category: London N]] | ||
[[Category: | [[Category: Lukacik P]] | ||
[[Category: | [[Category: Owen CD]] | ||
[[Category: Zaidman | [[Category: Powell AJ]] | ||
[[Category: | [[Category: Skyner R]] | ||
[[Category: Strain-Damerell CM]] | |||
[[Category: Walsh MA]] | |||
[[Category: Wild C]] | |||
[[Category: Zaidman D]] | |||
[[Category: Von Delft F]] | |||
Latest revision as of 09:22, 23 October 2024
PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhibitors -- Crystal Structure of SARS-CoV-2 main protease in complex with LON-WEI-adc59df6-39 (Mpro-x3117)
| ||||||||||||